Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes.

Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes. 2010 Dec; 59(12):3139-47.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.